|Denaro||183,51 x 800|
|Lettera||184,39 x 800|
|Min-Max giorno||182,41 - 185,14|
|Intervallo di 52 settimane||129,21 - 218,00|
|Beta (5 anni mensile)||0,26|
|Rapporto PE (ttm)||27,17|
|Prossima data utili||27 apr 2021|
|Rendimento e dividendo (forward)||3,40 (1,84%)|
|Data ex dividendo||11 feb 2021|
|Stima target 1A||215,91|
Indianapolis-based pharmaceutical giant Eli Lilly and Company reported better-than-expected profit in the fourth quarter, led by solid demand for its cancer and diabetes drugs, sending its shares up over 4% in pre-market trading on Friday.
Eli Lilly surged nearly 12% Monday after the big pharma firm reported encouraging results on an experimental Alzheimer’s drug.
Indianapolis-based pharmaceutical company Eli Lilly announced to acquire a biotechnology company Prevail Therapeutics in a deal worth $1.04 billion to expand its business in gene therapy, sending its shares up over 3% on Tuesday.